Position in INVA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$9,461,439
-$294,992 QoQ
Shares Held
416,620
-0.5% QoQ
Ownership
0.577%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. INVA ranks #38 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,461,439 | 416,620 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $9,756,431 | 418,731 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $6,778,728 | 339,106 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $5,287,480 | 289,725 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $6,302,232 | 313,700 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,538,279 | 305,476 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $5,166,412 | 297,776 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $5,537,663 | 286,777 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $5,032,094 | 306,835 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $4,937,622 | 323,991 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $5,178,834 | 322,870 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $4,292,895 | 330,477 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $4,449,770 | 349,550 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $4,409,966 | 391,997 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $5,337,444 | 402,826 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,850,773 | 417,810 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $6,951,604 | 470,976 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $9,616,621 | 496,983 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $9,208,809 | 533,844 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,133,401 | 546,583 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $7,457,126 | 556,087 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $6,828,623 | 571,433 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $7,000,906 | 565,045 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $5,597,552 | 535,651 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $7,765,400 | 555,465 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $6,430,967 | 546,851 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||